We are live on ! Find out more
KAM

Krensavage Asset Management Portfolio holdings

AUM $256M
1-Year Est. Return 69.63%
This Fund
S&P 500
This Quarter Est. Return
+3.04%
1 Year Est. Return
+69.63%
3 Year Est. Return
+113.28%
5 Year Est. Return
+196.5%
10 Year Est. Return
+463.27%
AUM
$277M
AUM Growth
-$811K
Cap. Flow
-$8.32M
Cap. Flow %
-3.01%
Top 10 Hldgs %
81.5%
Holding
20
New
–
Increased
14
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
IPXL
Impax Laboratories, Inc.
IPXL
+$8.1M
2
ENTA icon
Enanta Pharmaceuticals
ENTA
+$2.16M
3
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
+$1.78M
4
IVC
Invacare Corporation
IVC
+$1.7M
5
SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
+$242K

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$11.6M
2
AGN
Allergan plc
AGN
+$6.1M
3
ASRT
Assertio
ASRT
+$4.28M
4
OFIX icon
Orthofix Medical
OFIX
+$294K
5
CNMD icon
CONMED
CNMD
+$143K

Sector Composition

Rank Sector Weight
1 Healthcare 72.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$25.8B
$32.6M 11.77%
275,764
+516
+0.2% +$62K
OFIX icon
2
Orthofix Medical
OFIX
$477M
$27.4M 9.89%
639,851
-6,595
-1% -$294K
ENTA icon
3
Enanta Pharmaceuticals
ENTA
$366M
$26.6M 9.61%
999,741
+92,811
+10% +$2.16M
IPXL
4
DELISTED
Impax Laboratories, Inc.
IPXL
$24.5M 8.84%
1,032,187
+301,370
+41% +$8.1M
AMGN icon
5
Amgen
AMGN
$208B
$21M 7.6%
126,038
+236
+0.2% +$39.9K
SCMP
6
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$20.3M 7.35%
1,651,898
+20,500
+1% +$242K
AVNS
7
DELISTED
Avanos Medical
AVNS
$20M 7.22%
576,285
+1,079
+0.2% +$37.8K
TEVA icon
8
Teva Pharmaceuticals
TEVA
$40.8B
$18.3M 6.61%
397,412
+867
+0.2% +$45.2K
MRK icon
9
Merck
MRK
$322B
$16.1M 5.82%
270,406
+506
+0.2% +$29.6K
SRGA
10
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$13.1M 4.73%
139,370
+17,770
+15% +$1.78M
CNMD icon
11
CONMED
CNMD
$1.39B
$13.1M 4.72%
325,785
-3,357
-1% -$143K
IVC
12
DELISTED
Invacare Corporation
IVC
$11.7M 4.21%
1,043,111
+141,671
+16% +$1.7M
VXRT
13
DELISTED
Vaxart
VXRT
$5.21M 1.88%
246,683
+461
+0.2% +$7.29K
DSCI
14
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$4.13M 1.49%
884,000
-26,703
-3% -$125K
STRR
15
DELISTED
Star Equity Holdings
STRR
$2.46M 0.89%
9,642
+18
+0.2% +$4.75K
JNP
16
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$1.6M 0.58%
288,294
+539
+0.2% +$3.56K
ASRT
17
DELISTED
Assertio
ASRT
– –
-3,632
Closed -$4.28M
AGN
18
DELISTED
Allergan plc
AGN
– –
-26,416
Closed -$6.1M
SHPG
19
DELISTED
Shire pic
SHPG
– –
-63,166
Closed -$11.6M

Similar funds

CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
2
2Xideas Kusnacht, Switzerland $255M AUM 0.46% 1-Year Est. Return
CIM
Caldwell Investment Management Toronto, Ontario, Canada $255M AUM 36.87% 1-Year Est. Return
JFG
Juno Financial Group Richmond, Virginia $255M AUM
PIP
Palisades Investment Partners Santa Monica, California $255M AUM 50.52% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return
GAMC
Garner Asset Management Corp Plano, Texas $255M AUM 22.93% 1-Year Est. Return
TIA
Tiemann Investment Advisors Menlo Park, California $255M AUM 21.35% 1-Year Est. Return

Krensavage Asset Management's Q3 2016 Portfolio in Review

As of Q3 2016, Krensavage Asset Management held 20 positions worth $277M, down 0.29% from $278M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Krensavage Asset Management withdrew a net $8.32M in Q3 2016, closing 3 positions and reducing 3 holdings. Its most notable exit was Shire pic, an estimated $11.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 76% a quarter earlier.

Against the trend, Krensavage Asset Management added an estimated $8.1M to Impax Laboratories, Inc..

  • Krensavage Asset Management added most to Impax Laboratories, Inc. in Q3 2016, an estimated $8.1M increase.
  • Krensavage Asset Management's biggest Q3 2016 reduction was Orthofix Medical, cutting an estimated $294K.
  • Krensavage Asset Management fully exited Shire pic in Q3 2016, selling an estimated $11.6M.
  • Krensavage Asset Management's ten largest holdings make up 82% of its $277M portfolio in Q3 2016.
  • Krensavage Asset Management opened 0 new positions and closed 3 in Q3 2016.
  • Krensavage Asset Management's portfolio value fell 0.29% quarter-over-quarter to $277M.

Based on Krensavage Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.